Literature DB >> 26853883

Krüppel-like factor 2 promotes cell proliferation in hepatocellular carcinoma through up-regulation of c-myc.

Kailin Zou1, Xiaojie Lu1, Kun Ye1, Chunmei Wang1, Tiangeng You1, Jinlian Chen2,3,4.   

Abstract

Members of krüppel-like factor family have been shown to play critical roles in the development, metabolism and tumorigenesis. Our previous study demonstrated that up-regulationupregulation of KLF2 in livers from obese mice could promote hepatosteatosis. However, little is known about its effects in hepatocellular carcinogenesis. In the present study, we found that mRNA and protein expression of KLF2 was increased in primary HCC, when compared with that in adjacent normal liver. In vitro studies further showed that enforced overexpression of KLF2 expression enhanced, while its knockdown inhibited cell proliferation and invasion. At the molecular level, c-myc was a direct transcriptional target of KLF2 and a KLF2-binding site in the c-myc promoter bound specifically to KLF2 protein. Indeed, ablation of c-myc largely attenuated the proliferative roles of KLF2 in HCC cells. Therefore, our data highlight an important role for KLF2/c-myc pathway in HCC development and progression.

Entities:  

Keywords:  Cell proliferation; KLF2; c-myc; hepatocellular carcinoma; transcription

Mesh:

Substances:

Year:  2016        PMID: 26853883      PMCID: PMC4847808          DOI: 10.1080/15384047.2015.1108484

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  23 in total

Review 1.  Analysis of genomic targets reveals complex functions of MYC.

Authors:  Jagruti H Patel; Andrey P Loboda; Michael K Showe; Louise C Showe; Steven B McMahon
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

Review 2.  Sp/KLF family and tumor angiogenesis in pancreatic cancer.

Authors:  Weihua Jiang; Jiujie Cui; Dacheng Xie; Liwei Wang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma.

Authors:  Francesca Zammarchi; Mariangela Morelli; Michele Menicagli; Claudio Di Cristofano; Katia Zavaglia; Alessandra Paolucci; Daniela Campani; Paolo Aretini; Ugo Boggi; Franco Mosca; Andrea Cavazzana; Luca Cartegni; Generoso Bevilacqua; Chiara Maria Mazzanti
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

4.  Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.

Authors:  Qi Li; Yong Gao; Zhiliang Jia; Lopa Mishra; Kun Guo; Zhiwei Li; Xiangdong Le; Daoyan Wei; Suyun Huang; Keping Xie
Journal:  Gastroenterology       Date:  2012-06-04       Impact factor: 22.682

Review 5.  The role of signaling pathways in the development and treatment of hepatocellular carcinoma.

Authors:  S Whittaker; R Marais; A X Zhu
Journal:  Oncogene       Date:  2010-07-19       Impact factor: 9.867

Review 6.  Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.

Authors:  Augusto Villanueva; Beatriz Minguez; Alejandro Forner; Maria Reig; Josep M Llovet
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

7.  Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.

Authors:  Lijian Hui; Kurt Zatloukal; Harald Scheuch; Ewa Stepniak; Erwin F Wagner
Journal:  J Clin Invest       Date:  2008-11-06       Impact factor: 14.808

8.  Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.

Authors:  Yukiko Nakahara; Paul A Northcott; Meihua Li; Paul N Kongkham; Christian Smith; Hai Yan; Sidney Croul; Young-Shin Ra; Charles Eberhart; Annie Huang; Darell Bigner; Wesia Grajkowska; Timothy Van Meter; James T Rutka; Michael D Taylor
Journal:  Neoplasia       Date:  2010-01       Impact factor: 5.715

9.  Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.

Authors:  Ze-Shiang Lin; Hsiao-Chien Chu; Yi-Chen Yen; Brian C Lewis; Ya-Wen Chen
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 10.  Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.

Authors:  Masahiro Tanaka; Francisco Katayama; Hideaki Kato; Hideo Tanaka; Jianbing Wang; You Lin Qiao; Manami Inoue
Journal:  J Epidemiol       Date:  2011-10-22       Impact factor: 3.211

View more
  6 in total

1.  Methylation of kruppel-like factor 2 (KLF2) associates with its expression and non-small cell lung cancer progression.

Authors:  Wenbin Jiang; Xueqing Xu; Shaoli Deng; Jie Luo; Huan Xu; Chao Wang; Tingting Sun; Guoqin Lei; Fengling Zhang; Cheng Yang; Lin Zhou; Feng Wang; Ming Chen
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

2.  Nucleoside diphosphate kinase B promotes osteosarcoma proliferation through c-Myc.

Authors:  Shijie Li; Tu Hu; Ting Yuan; Dongdong Cheng; Qingcheng Yang
Journal:  Cancer Biol Ther       Date:  2018-04-13       Impact factor: 4.742

3.  KLF2 Inhibits the Migration and Invasion of Prostate Cancer Cells by Downregulating MMP2.

Authors:  Binshuai Wang; Mingyuan Liu; Yimeng Song; Changying Li; Shudong Zhang; Lulin Ma
Journal:  Am J Mens Health       Date:  2018-12-06

4.  Bioinformatics analysis of KLF2 as a potential prognostic factor in ccRCC and association with epithelial-mesenchymal transition.

Authors:  Fangfang Hu; Yan Ren; Zunyun Wang; Hui Zhou; Yumei Luo; Minghua Wang; Faqing Tian; Jian Zheng; Juan Du; Gang Pang
Journal:  Exp Ther Med       Date:  2022-07-05       Impact factor: 2.751

5.  Knocking Out SST Gene of BGC823 Gastric Cancer Cell by CRISPR/Cas9 Enhances Migration, Invasion and Expression of SEMA5A and KLF2.

Authors:  Wei Chen; Ruixian Ding; Jinlu Tang; Haodong Li; Chonghua Chen; Yaru Zhang; Qinxian Zhang; Xiaoyan Zhu
Journal:  Cancer Manag Res       Date:  2020-02-20       Impact factor: 3.989

6.  Krüppel-like factor 2 suppresses human gastric tumorigenesis through inhibiting PTEN/AKT signaling.

Authors:  Chunmei Wang; Liang Li; Qiuhui Duan; Qingqing Wang; Jinlian Chen
Journal:  Oncotarget       Date:  2017-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.